ISSN 0975-3583
 

Journal of Cardiovascular Disease Research

2021, Vol: 8, Issue: 8
Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles
Required files to be uploaded

Copyright


    STUDY OF INCIDENCE, OUTCOME AND SIDE-EFFECT PROFILE OF INH MONORESISTANT TB TREATED WITH H MONO POLY DR REGIMEN


    Dr. VARIKUTI APARNA, MD, Dr. KOLA VIJAYA KISSINGER,MD, Dr. BHARGAVI ARUMUGAM, Dr.GORTHI ARUNA, MD
    JCDR. 2024: 1141-1147

    Abstract

    INH is an important first line Anti TB drug and unexpectedly, Mono resistance to INH has been found to be as high as 17.3% in India as per the India TB Report, 2023. This reduces treatment success rates and increases incidence of MDR-TB. The regimen used in these patients as per guidelines is 6LRZE (6 months of Levofloxacin, Rifamycin, Ethambutol and Pyrazinamide) AIM AND OBJECTIVE -To study the incidence, outcome and side effect profile of INH mono resistant TB when treated with H Mono Poly DR Regimen and to study the side effects of long term usage of Levofloxacin and Pyrazinamide. METHODOLOGY- 78 INH Mono resistant patients were diagnosed at the Designated Microscopy centre attached to the Respiratory Medicine OP, ACSR Govt. Medical College between 1st January 2023 and 1st July 2023 (6 months) and H Mono Poly DR regimen started.

    Description

    » PDF

    Volume & Issue

    Volume 15 Issue 3

    Keywords
Submit Article
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The articles in Journal of Cardiovascular Disease Research are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Copyright � 2022 Journal of Cardiovascular Disease Research All Rights Reserved. Subject to change without notice from or liability to Journal of Cardiovascular Disease Research. For best results, please use Internet Explorer or Google Chrome


POLICIES & JOURNAL LINKS

Contact Information


Journal of cardiovascular Disease Research,
No: 763-1/A Gandhi Road-2 Vimal Guptha Residency, Nauroji Nagar- New Delhi 110029

Phone : 0975-3583, 0976-2833

editor@jcdronline.org